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Abstract In this paper we introduce monobromobimane, a thiol 
reagent, as a selective blocker of the recently identified dithiol 
whose oxidation-reduction status modifies voltage sensing by the 
mitochondrial permeability transition pore, a cyclosporin A-sen- 
sitive channel. Monobromobimane does not inhibit the phosphate 
carrier, nor does it interfere with Ca 2+ transport, energy coupling 
or ATP production and transport. We show that monobromo- 
bimane selectively prevents the shift in pore gating potential 
caused by some dithiol oxidants or crosslinkers but not by in- 
creasing [Ca2+], allowing a clear distinction of the pore agonists 
which act at this site. 
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1. Introduction 
The mitochondrial permeability transition pore (MTP) is an 
inner membrane channel activated by matrix Ca 2+, inhibited by 
matrix H ÷ and by cyclosporin A, and modulated by an array 
of effectors acting at discrete sites [1-6] (see also [7,8] for re- 
views). We have recently identified the membrane potential as 
a key MTP effector, showing that the pore behaves as a voltage- 
dependent channel exhibiting an increased open probability 
upon depolarization [9]. In a recent study investigating the 
mechanism of voltage sensing by the MTP, we have described 
a critical dithiol whose oxidation-reduction state modulates the 
pore response to a given membrane potential. Dithiol oxidation 
or cross-linking is associated to a higher open probability, and 
this effect can be reversed by disulfide reduction or prevented 
by thiol substitution with N-ethylmaleimide (NEM) [10]. Here 
we show that monobromobimane (MBM), a syn-9,10-dioxa- 
bimane bromoderivative which selectively reacts with thiol 
groups [11], prevents the shift in MTP gating potential caused 
by some dithiol oxidants or crosslinkers. At variance from 
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NEM, MBM does not inhibit the Pi carrier, nor does it interfere 
with Ca 2+ transport, energy coupling or ATP production and 
transport. MBM is thus a selective ffector of the MTP at the 
above-mentioned dithiol, allowing a discrimination of the pore 
agonists which act at this site. Since upon binding to protein 
thiol groups a fluorescent product is formed, MBM can also 
become an important tool for sensor tagging and isolation. A 
portion of this work has been presented in Abstract form [12]. 
2. Materials and methods 
Rat liver mitochondria were prepared as described previously [13], 
except hat the last washing included 0.1 mM EGTA-Tris while bovine 
serum albumin was omitted. The fraction of mitochondria permeabil- 
ized to sucrose, a measure of MTP opening, and mitochondrial mem- 
brane potential were determined exactly as described in [14] and [15], 
respectively. Respiration was determined with a Clark oxygen electrode 
(Yellow Springs Instruments, Ohio), and the rate of P, transport was 
determined asdescribed in [16]. Ca 2÷ fluxes were followed at 650 minus 
690 nm with an Aminco DW2a dual wavelength spectrophotometer in 
incubations containing 25/IM Arsenazo III and 20/IM Ca 2+. The rate 
of Ca 2÷ uptake on the Ca 2÷ channel (uniporter) was measured with the 
method of Bragadin et al. [17] in respiratory-inhibited mitochondria 
incubated ina sucrose-based medium. Ca 2+ uptake was initiated by the 
addition of excess valinomycin, thus ensuring that the flux was meas- 
ured under true rate-limiting conditions [17]. The rate of Ca 2÷ efflux on 
the Na+-independent pa hway was studied by adding 0.1 mM ruthe- 
nium red to succinate-energized mitochondria which had accumulated 
40 nmol Ca 2÷ "rag protein 1 in the presence of 1 mg. ml -~ cyclosporin 
A. MBM and trimethylammonium-MBM (THIOLYTE) were pur- 
chased from Calbiochem, and all chemicals were of the highest purity 
commercially available. Incubation conditions and details of the exper- 
imental protocols are given in the figure legends. 
3. Results 
The MTP voltage dependence an be studied in a mitochon- 
drial population by following the fraction of mitochondria 
which become permeable to sucrose (an indication of MTP 
opening) as a function of the membrane potential (AT), as 
varied with different concentrations of the uncoupler carbon- 
ylcyanide-p-trifluoromethoxyphenyl hydrazone (FCCP) [14]. 
Conditions have to be chosen so as to prevent matrix acidifica- 
tion (which would inhibit the MTP), e.g. by P~, and Ca 2+ efflux, 
e.g. by Ruthenium red or EGTA [14]. The lower the concentra- 
tions of FCCP needed to open the pore, the higher the gating 
potential, which can be measured from A T determinations of 
parallel samples treated with cyclosporin A [14]. 
The experiments of Fig. 1 show that after accumulation of 
a small Ca 2+ load in the presence of 1 mM P~ the addition of 
30 nM FCCP, corresponding to a depolarization of about 45 
mV, was not sufficient o trigger MTP opening (panel 1, trace 
a). If the addition of FCCP was preceded by that of the arsenite 
anion (AsO), on the other hand, identical concentrations of
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FCCP caused now pore opening in > 75% of the mitochondria, 
indicating a shift of gating potential to higher values (panel 1, 
trace b). This shift could be prevented by increasing concentra- 
tions of MBM (panel 1, traces c-f), as is also the case for the 
sulfhydryl group reagent, NEM [10]. Similar effects of MBM 
were observed if the shift of the responding population was 
obtained with the addition of the dithiol oxidant, diamide 
(DIA) rather than of AsO (see Fig. 3). Fig. 1, panel 2, shows 
the concentration-dependence of the MBM inhibition, which 
displayed an apparent 150 of about 7/.tM (closed symbols). At 
variance from MBM, a positively charged trimethylammonium 
MBM derivative (MBM ÷) was completely ineffective (open 
symbols) even at a concentration of 100 mM (data not shown). 
Parallel titrations of the membrane potential as a function of 
the FCCP concentration i the absence or presence of AsO and 
of MBM, and including cyclosporin A to block pore opening, 
indicated identical dose response curves (not shown, but see 
Fig. 1 [10]). Thus, the effects of MBM are not due to a direct 
modification of the A 7, nor to a modification of its response to 
uncoupler. Rather, MBM appears to prevent he shift in gating 
potential caused by dithiol cross-linking or oxidation, most 
likely by reacting with the same NEM-sensitive site character- 
ized previously [10]. 
In the experiments of Fig. 2 we measured the rate of P~ 
transport at increasing concentrations of MBM (closed sym- 
bols) or of NEM (open symbols). It can be clearly appreciated 
that, at variance from NEM (used here as a positive control 
[16]), MBM was totally ineffective as an inhibitor of the P~ 
carrier at concentrations which fully prevented the AsO-in- 
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Fig. 1. Inhibitory effect of MBM, but not of a trimethylammonium 
MBM derivative, on MTP opening induced by a small depolarization 
in the presence of AsO. The incubation medium contained 0.2 M Su- 
crose, 10 mM Tris-MOPS pH 7.4, 5 mM Succinate-Tris, 1mM Pi-Tris, 
10 ¢tM EGTA-Tris, 2 I~M Rotenone, 0.5/.tg'ml -I oligomycin. Final 
volume 2 ml, 25°C. The experiments were started by the addition of 
1 mg of mitochondria (not shown). Panel 1. Where indicated (the first 
addition being made exactly 1 min after mitochondria) the following 
additions were made: 10 #M Ca 2+, MBM (traces c-f only) 0.5 ,uM AsO 
(traces b-f), 0.5 mM EGTA and 30 nM FCCP. The final MBM concen- 
tration was 5/~M (trace c), 8 ¢tM (trace d), 15 ¢tM (trace e) or 25 ¢tM 
(trace f). Note that the trace obtained after addition of 30 nM FCCP 
in the absence of MBM and AsO (trace a) was indistinguishable from 
that obtained in the presence of 0.5/~M AsO and 25 ,uM MBM (trace 
f). The traces were obtained by following the light scatter of the mito- 
chondrial suspension at 540 nm, and were calibrated to obtain the 
fraction of permeabilized mitochondria (~) as described [14]. Panel 2. 
Dose-dependence of the effects of MBM (closed symbols) or of MBM + 
(open symbols) on the fraction of mitochondria with an open pore in 
protocols identical to those depicted in panel 1, where only selected 








Fig. 2. Inhibition of P, transport by NEM but not by MBM. NEM 
(open circles) or MBM (closed circles) were added to 1 mg ofmitochon- 
dria in 0.1 ml of 0.25 M Sucrose, 10 mM Tris-HC1, pH 7.4, 0.1 mM 
EGTA-Tris in a stirred cuvette thermostatted at 25°C. After exactly 
one minute, 1.9 ml of 0.1 M NH4-Pi, pH 7.4, 0.5 mM EGTA-Tris, 2/IM 
Rotenone were added. The rate of P~ transport was followed as the rate 
of absorbance change at 540 nm, and values on the ordinate are ex- 
pressed as the percent of the rate observed in the absence of NEM or 
MBM. Values on the ordinate refer to the final concentrations of NEM 
or MBM during the assay. 
to study the regulation of MTP voltage sensing under condi- 
tions where P~ fluxes are unaffected. 
A set of experiments was carried out to determine whether 
MBM interferes with other mitochondrial functions which are 
relevant to operation of the MTE We found (results not 
shown) that treatment of mitochondria with 50 nmol .mg pro- 
tein-Z of MBM did not modify (i) the rate of basal or of uncou- 
pler-stimulated respiration with succinate or glutamate/malate 
as substrates, indicating that MBM is neither an uncoupler nor 
a respiratory inhibitor; (ii) the ADP/O ratio, indicating that 
MBM does not interfere with either the adenine nucleotide 
translocator or the F1F0 ATPase; (iii) the rate of Ca 2+ uptake 
on the Ca 2+ channel (uniporter) measured under conditions 
where the transport reaction is rate limiting [17]; and (iv) the 
rate of Na+-insensitive Ca 2+ efflux after addition of ruthenium 
red to energized mitochondria that had accumulated 40 nmol 
CaZ+.mg protein-~ in the presence of 1 #g. ml-I cyclosporin A; 
the last two points indicate that MBM is not interfering with 
Ca 2+ homeostasis. We must stress that in all cases the record- 
ings obtained in the presence of MBM were indistinguishable 
from those obtained in its absence. As MBM does not influence 
Ca 2+ fluxes and energy coupling we could then test its effects 
on the gating profile as modified by a variety of agents, includ- 
ing increasing Ca 2+ concentrations. 
Fig. 3 summarizes the results of a series of experiments where 
the FCCP-dependence of MTP opening in increasing fractions 
of mitochondria (O~) was modulated by the addition of AsO or 
by an increase of the Ca 2+ load. A different mitochondrial 
preparation was used for each set of experiments. Since the 
FCCP-dependence at a given Ca z÷ load can vary depending on 
the concentration of intramitochondrial pore effectors (such as 
endogenous P~, Ca z+, Mf  + and adenine nucleotides) and possi- 
bly on other unknown factors, we have obtained a similar 
'basal' profile for each set of experiments by adjusting the Ca 2+ 
concentration by trial and error (10 or 15/IM for panels 1 and 
2, respectively) in order to obtain comparable profiles with both 
preparations (open circles in both panels). Then, the shift of 
MTP opening profile was obtained by either the addition of 
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Fig. 3. Effect of MBM on the fraction of mitochondria permeabilized 
to sucrose at increasing FCCP concentrations. Incubation conditions 
and sequence of additions were as in Fig. 1. One minute after mitochon- 
dria, the following additions were made. Panel 1:10/~M Ca 2*, 0.5 mM 
EGTA-Tris and FCCP (open circles); the same with 25/tM DIA added 
after Ca 2+ (open triangles); the same with 25/tM MBM added before 
DIA (closed circles). Panel 2:15/IM Ca 2÷, 0.5 mM EGTA-Tris and 
FCCP (open circles); 30/~M Ca 2÷, 0.5 mM EGTA-Tris and FCCP 
(open triangles); the same with 25/IM MBM added after 30/IM Ca 2÷ 
(closed circles). 
DIA (panel 1) or by an increase of the Ca 2+ load (panel 2) (open 
triangles in both panels). The experiments clearly document 
that MBM fully prevented the shift due to DIA (panel 1) but 
not that due to an increased Ca 2+ load (panel 2) (closed 
circles). 
4. Discussion 
In this paper we have shown (i) that MBM, a selective thiol 
reagent [11], is able to specifically prevent he effects of DIA, 
a dithiol oxidant [18], and of AsO, a dithiol crosslinker [19], at 
a site which appears to modulate voltage sensing by the MTP 
[10]; (ii) that MBM does not affect he transport of P~, Ca 2÷, and 
adenine nucleotides; (iii) that respiration and ATP synthesis are 
not affected by this reagent. Thus, MBM behaves as a site- 
specific pore reagent lacking side effects on mitochondrial func- 
tion. 
In a previous paper we have shown that NEM has identical 
effects on the shift of MTP voltage sensing induced by DIA and 
AsO to those reported here for MBM [10]. Two problems, 
however, seriously limit the potential use of NEM in this capac- 
ity. The first problem is that NEM inhibits the P~ carrier [16] 
in the same concentration range as it modifies the putative 
voltage sensor [14]. Pi is an important factor regulating the 
MTP, and its effects are synergistic with those of Ca 2+, in part 
because of its buffering effects on matrix pH (see e.g. [20]). In 
a previous paper demonstrating the inhibitory effects of NEM 
on MTP modulation by the redox status of the DIA- and 
AsO-reactive dithiol the protocols had to be carefully defined 
to circumvent the potential problems posed by inhibition of the 
P~ carrier [10]. It is reassuring that identical results could be 
obtained with MBM (Figs. 1 and 2), and that the findings of 
the present work are fully consistent with our recent demon- 
stration that mersalyl does not interact with the MBM- and 
NEM-reactive dithiol at concentrations which fully inhibit P~ 
transport [2l]. The second problem is that NEM behaves as a 
pore inducer when used at concentrations which are only 
slightly higher than those needed to fully block the AsO- and 
DIA-sensitive site [14,22] thus limiting the useful NEM concen- 
trations to a rather narrow range. None of these limitations 
applies to MBM as shown by its lack of effects on Pi transport 
(Fig. 2) and by its lack of activity as a pore inducer at concen- 
trations up to 1 mM (data not shown). Thus, MBM is superior 
to NEM both in terms of specificity and of lack of side effects. 
There is now little doubt that the MTP behaves as a voltage- 
dependent channel which increases its open probability upon 
depolarization ([8] and references therein). We proposed (i) that 
many signalling molecules and pharmacological gents could 
modulate the probability of pore opening by modifying its 
response to a given voltage (i.e., its voltage sensing) rather than 
by acting on the membrane potential itself [14]; and (ii) that an 
AsO- and DIA-sensitive dithiol was a factor in voltage sensing 
[10]. As shown here, the increased probability of pore opening 
at a given membrane potential observed at increasing Ca 2+ 
loads ([14] and Fig. 3) is not mediated by the AsO and DIA- 
sensitive dithiol, since the Ca2+-dependent shift of the FCCP 
dose-response curve for MTP opening was completely insensi- 
tive to MBM (Fig. 3). 
It should be appreciated that MBM is not a pore inhibitor 
in an absolute sense, since it only prevents the modulatory 
effects of DIA and AsO rather than preventing MTP opening 
generally, and that its unique properties would have gone unde- 
tected in the traditional 'spontaneous' swelling assays. In the 
latter protocols, the MTP agonist or antagonist is added to a 
mitochondrial suspension at a fixed Ca 2÷ load, and the effect 
is then generally observed as a change in the apparent rate of 
spreading of the permeability ransition through the mitochon- 
drial population, which usually follows a lag phase of variable 
duration. The kinetics are always non-linear, and quantifica- 
tion is difficult and often deceptive because subpopulations of
permeable and non-permeable mitochondria coexist, and Ca 2+ 
is therefore continuously transferred from permeabilized to still 
impermeable mitochondria. This also causes secondary 
changes of membrane potential and of matrix pH (i.e. the other 
two main factors controlling the probability of MTP opening) 
in mitochondrial subpopulations, making quantification and 
establishment of correlations extremely difficult. 
The protocol we introduced, namely the determination f the 
apparent voltage dependence of pore opening in increasing 
fractions of mitochondria [14] circumvents most of these prob- 
lems because (i) the correlation between fraction of permeabil- 
ized mitochondria and absorbance or light scattering change is 
linear; (ii) the transition can be triggered simultaneously for all 
the responding mitochondria by depolarization after blockade 
of the Ca -'+ channel with either ruthenium red or EGTA, thus 
preventing Ca -'+ redistribution and all the secondary changes 
mentioned above; and (iii) the critical factors modulating MTP 
activity (matrix Ca 2÷ and pH, and transmembrane voltage) can 
be kept relatively constant and measured for the total popula- 
tion before the permeability ransition is initiated [14]. Because 
of these features, this protocol allows an objective and repro- 
ducible quantification of the phenomenon under study. The 
only additional requirement is to perform independent titra- 
tions of the membrane potential to insure that the observed 
shifts do not depend on direct uncoupling or on respiratory 
inhibition [14]. It is clear that a shift in the apparent voltage 
dependence does not necessarily mean that the agonist or an- 
tagonist is acting through the putative MTP voltage sensor. 
Yet, as shown here, this method can allow a clear discrimina- 
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tion of whether different agonists act at the same or at different 
site(s), and recently allowed the identification of protoporphy- 
rin IX as a powerful MTP agonist [23]. 
MBM +, a derivative which has the same chemical reactivity 
of MBM but carries a net positive charge [11], is ineffective at 
blocking the MBM-sensitive site (Fig. 1). At variance from 
MBM, the former species does not readily permeate through 
cellular membranes [11], suggesting that the reactive site may 
be either internal or buried within the mitochondrial mem- 
brane(s). An alternative possibility is that the reactive site car- 
ries a net positive charge which would oppose the binding of 
MBM +. The unequivocal assignement of pore effectors to def- 
inite channel domains or regulatory mechanisms must await 
pore isolation and reconstitution. Since upon its binding to 
protein thiol groups a fluorescent product is formed [11], MBM 
could also be useful for pore tagging and isolation. The feasibil- 
ity of this approach is being actively tested in our laboratory. 
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